Pulse Biosciences (PLSE) Other Accumulated Expenses (2015 - 2025)

Pulse Biosciences' Other Accumulated Expenses history runs 11 years deep, the most recent figure standing at $363000.0 for Q4 2025.

• On a quarterly basis, Other Accumulated Expenses rose 93.09% year-over-year to $363000.0 in Q4 2025; TTM through Dec 2025 was $363000.0, a 93.09% increase from a year earlier, with the FY2025 full-year figure at $363000.0, up 93.09% from the prior year.
• Other Accumulated Expenses advanced to $363000.0 in Q4 2025 per PLSE's latest filing, from $351000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.2 million in Q1 2021 and bottomed at $167000.0 in Q2 2024.
• The 5-year median for Other Accumulated Expenses is $213500.0 (2022), against an average of $348550.0.
• Across the five-year window, Other Accumulated Expenses surged 1786.21% in 2021 and tumbled 86.52% in 2022, its largest moves.
• Year by year, Other Accumulated Expenses stood at $513000.0 in 2021, then plunged by 58.09% to $215000.0 in 2022, then slipped by 12.56% to $188000.0 in 2023, then changed by 0.0% to $188000.0 in 2024, then jumped by 93.09% to $363000.0 in 2025.
• Per Business Quant, the three latest PLSE Other Accumulated Expenses figures stand at $363000.0 (Q4 2025), $351000.0 (Q3 2025), and $212000.0 (Q2 2025).